Figure 4 Side effects
How has this study helped patients and researchers?
The results from this study showed that the HibCY vaccine was similar to the Hib vaccine and can be
given to babies together with the other commonly used vaccines.
Are there plans for further studies?
No further studies are planned for the HibCY vaccine.
Where can I find more information about this study?
The detailed title for this research study is:
A phase IIIb, open, randomized, controlled, multicenter study to assess the co-administration of Rotarix
(GlaxoSmithKline Biologicals’) with Hib-MenCY-TT (GlaxoSmithKline Biologicals’ Meningococcal Groups C
and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine) at 2 and 4 months of age, the co-
administration of Prevnar 13 (Pfizer) with Hib-MenCY-TT at 2, 4 and 6 months of age and the co-
administration of Prevnar 13 and Havrix (GlaxoSmithKline Biologicals’) with Hib-MenCY-TT at 12 to 15
months of age.
Clinical studies have unique study numbers. Below are the unique study numbers associated with this
study.